Cargando…
Use of triiodothyronine to treat critically ill COVID-19 patients: a new clinical trial
Autores principales: | Pantos, Constantinos, Tseti, Ioulia, Mourouzis, Iordanis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209969/ https://www.ncbi.nlm.nih.gov/pubmed/32384906 http://dx.doi.org/10.1186/s13054-020-02934-2 |
Ejemplares similares
-
Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial
por: Pantos, Constantinos, et al.
Publicado: (2020) -
Triiodothyronine prevents tissue hypoxia in experimental sepsis: potential therapeutic implications
por: Mourouzis, Iordanis S., et al.
Publicado: (2021) -
Effects of Thyroid Hormone on Tissue Hypoxia: Relevance to Sepsis Therapy
por: Lourbopoulos, Athanasios I., et al.
Publicado: (2021) -
The Potential of Thyroid Hormone Therapy in Severe COVID-19: Rationale and Preliminary Evidence
por: Mourouzis, Iordanis, et al.
Publicado: (2022) -
Thyroid Hormone and Tissue Repair: New Tricks for an Old Hormone?
por: Mourouzis, Iordanis, et al.
Publicado: (2013)